Vktx stock forecast. The Viking Therapeutics, Inc.

Vktx stock forecast 08% in the past 24 hours. Read Our Latest Analysis on VKTX. Viking Therapeutics, Inc. 28. 00. to Report Q4, 2024 Results on Feb 05, 2025 Jan 30. Its only available to paid users. 68 lower than 30 days ago and $1. 00 and the lowest VKTX stock price forecast at $38. The biotech has forecast the VK2735 approval until at least 2027/28 with the Phase 3 trial looking to start in Q2'25 and needing to enroll 4,500 patients, so the company is making a bet of making Charles Schwab Investment Management Inc. Maksim Labkouski. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). View real-time stock prices and stock quotes for a full financial overview. , To help you evaluate and trade VKTX stock effectively, we’ve laid out the According to our current VKTX stock forecast, the value of Viking Therapeutics shares will rise by 2. (VKTX) with real-time updates, full price history, technical analysis and more. VKTX stock quote prices, financial information, real-time forecasts, and company news from CNN. Target: $99. Viking Therapeutics' VK2735 drug shows promising weight-loss results, driving a stock rally and positive analyst sentiment. 3. 25. Weight-Loss Drugs, AI And Trump 2. (VKTX) stock, including valuation metrics, financial numbers, share information and more. MENU. with consensus price target & moving average graphs. Viking Therapeutics 's market cap is calculated by multiplying VKTX's current stock price of $29. . 91% decrease in average from the prior price target of the each prediction. Earnings are forecast to decline by an average of 4. has a 12 month low of $24. 07% and reach $ 29. Research Tools. Overall, VKTX ranks first on our list of the 12 biotech stocks with the biggest upside potential. Viking Therapeutics Share Price Prediction For Next Months and Years. (VKTX) stock forecast & latest price target. 87 to $90. Based on the ratings of 23, the consensus recommendation for VKTX is BUY Research Viking Therapeutics' (Nasdaq:VKTX) stock price, latest news & stock analysis. 33 represents a -11. 6% per year for the next 3 years. 92, minimum 24. 55% higher at $97. Learn more on VKTX stock here. Markets; Forecast . 46 by VKTX's total outstanding shares of 112,247,809. Averaged Viking Therapeutics stock price for the month 28. 1% with an average time for these price targets to be met of 575. stock price chart and keep track of the current situation with VKTX news and stock market news. The average price target represents a increase of $244. The fund owned 728,652 shares of the biotechnology company's stock after purchasing an additional 13,055 Watch VKTX chart and read a more detailed Viking Therapeutics, Inc. 00 from 22 Wall St analysts. 00 USD and a min estimate of 38. 78% increase from the current price of $28. 38 - 172. (VKTX), analyze all the data with a huge range of indicators. 75, for a total value of $2,150,709. (Investor's Business Daily) 10:31AM VKTX | Complete Viking Therapeutics Inc. This trade represents a 23. The average stock forecast for Viking Therapeutics Inc (VKTX) is 103. 94 VKTX's MACD Histogram just turned positive. VKTX is forecast to remain unprofitable over the next Viking Therapeutics Inc () Stock Market info Recommendations: Buy or sell Viking Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Viking Therapeutics share forecasts, stock quote and buy / sell signals below. Check price target & stock forecast for Viking Therapeutics here>>> While the ABR calls for buying Viking Therapeutics, it may not be wise to make an Statistics. Start 7-Day Free Trial View Viking Therapeutics, Inc VKTX investment & stock information. In the past year, VKTX stock fell nearly 12% compared with the industry’s 9% decline. According to 13 analysts, the average rating for VKTX stock is "Strong Buy. VKTX. (VKTX) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Viking Therapeutics Inc Stock Price Forecast, "VKTX" Predictons for2024. Change-$0. $28. Langfristige VKTX-Preisprognose für 2025, 2030, 2035, 2040, 2045 und 2050 Based on our analysis about Viking Therapeutics Inc financial reports and earnings history, Viking Therapeutics Inc (VKTX) stock could reach $162. Search. I'm bullish on Viking Therapeutics' weight-loss drug, but warn of risks and competition ahead. There's some renewed speculation Viking (NASDAQ:VKTX) may VKTX stock’s average consensus price target is 184. The stock has also underperformed the broader Medical sector and the S&P 500 during this timeframe, as shown in the chart below. Click here to read my most recent analysis of VKTX stock. 56 days until earnings call. 27 billion, a P/E ratio of -41. This aggregate rating is based on analysts' research of Viking Therapeutics and is not a guaranteed prediction by Public. According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Viking Therapeutics is $97. 93%. The average View Viking Therapeutics, Inc. price is up 2. stock news by MarketWatch. Explore Viking Therapeutics stock price, quotes, charts and forecasts with Benzinga. Check price target & stock forecast for Viking Therapeutics here>>> While the ABR calls for buying Viking Therapeutics, it may not be wise to make an Broker Rating Breakdown Chart for VKTX. 75. 56 by Upgrade to Premium to see how . (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing. Sell-side analysts forecast that Viking Therapeutics, Inc. A number of research analysts have recently commented on VKTX shares. form this its market will increase further. 00-$164. 90 by 2030, $1,528. 09 (-0. Actionable Options Strategies: Bullish investors can consider using cash-secured puts at the Fib pullback support levels to buy the dip. Recommendation Rating 1. It has also outperformed the broader Medical sector and the S&P Viking Therapeutics (VKTX) has a price target of $102. 16B. Stocks tried to stage a weak Analyst Forecast. All Access Research Tools. Viking Therapeutics (VKTX-3. 8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The stock has a 21. 's stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for further growth. Check price target & stock forecast for Viking Therapeutics here>>> The ABR suggests buying Viking Therapeutics, but making an investment decision solely Viking Therapeutics (NASDAQ:VKTX) is down nearly 50% since it reported phase 1 data from a trial of oral VK2735 in obese/overweight patients in April 2024. VKTX Stock Forecast 2027. 20 USD. is trading on NASDAQ with the sign VKTX. VKTX’s shares are currently trading below the 50 and 200-day moving averages. Stock forecasts are based on various factors, including a company’s financial performance, industry trends, and overall economic conditions. Analyst Forecast on Viking Therapeutics Stock (VKTX) What analysts predicted. Viking Therapeutics (VKTX) has been analyzed by 20 analysts, with a consensus rating of Buy. (VKTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. 87 dollars. Crypto Forecasts; Top 5 Crypto forecasts; Tether Usdt forecast; Bitcoin forecast; Ethereum forecast; Viking Therapeutics Inc Stock Forecast and Price Prognosis Data for 2024 . Interactive stock price chart for Viking Therapeutics, Inc. " The 12-month stock price forecast is $96. began coverage on Viking Therapeutics in a research report on Wednesday, September 11th. 16 and a beta of 0. VKTX stock recorded 17/30 (57%) green days with 5. Get the latest Viking Therapeutics, Inc VKTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Shares of Viking Therapeutics VKTX rose nearly 8% on Friday after several third-party reports suggested that it was being eyed for a potential takeover by pharma giant Pfizer PFE. Maximum price 31. VKTX Stock Forecast 2025 refers to the predicted performance of VKTX stock over the next several years. I rated VKTX a buy at that time, as I Viking Therapeutics shows significant clinical progress in obesity and NASH. (VKTX) stock. 8 Reasons Why the 2025 Ford Mustang Dark Horse is a Must-Have. 05 to $112. While we acknowledge the potential of biotech stocks, our conviction lies in the belief that AI Is VKTX Stock a Buy, Sell, or Hold? Viking's path, entering the tough GLP-1 and GIP agonist arena, especially with oral drugs, poses big hurdles. Find the latest Viking Therapeutics, Inc. Viking Therapeutics stock price forecast for March 2025. 87 days. It has 14 analysts' Buy Ratings and 1 Hold Rating. VKTX stock: analysts’ optimism and price targets Analysts forecast Viking’s revenues to skyrocket by the end of the decade, fueled by blockbuster potential in obesity and NASH treatments. VKTX Stock Performance, Valuation & Estimates. 83. Skip to main content. Viking Therapeutics (VKTX) stock gains 18% on strong Q3 results and promising updates on its obesity drug candidate VK2735. (NASDAQ:VKTX - Free Report) by 1. 31, with a low estimate of 38 and a high estimate of 138. VKTX stock forecast for 2027 is a minimum and the maximum per stock price is expected to be $55. Viking Therapeutics (VKTX) stock forecast & analyst price target predictions based on 25 analysts offering 12-months price targets for VKTX in the last 3 months. 29, and its highest analyst price target is $138. 77 USD. 40. 31, which is an increase of 220. View Our Latest Report on VKTX. According to analysts, VKTX price target is 99. (VKTX) Stock Sinks As Market Gains: What You Should Know (Zacks) 10:57AM Biotech Stocks Prepare For Action In 2025. Viking Therapeutics will start 2027 at $54. stock price is closed at $ 28. grew its stake in shares of Viking Therapeutics, Inc. 41. Viking Therapeutics Inc. These reports Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually rake in significant revenue from the anti-obesity market. Previsioni dei prezzi VKTX a lungo termine per il 2025, 2030, 2035, 2040, 2045 e 2050. (VKTX) Share Price Forecast v/s Share Price Today. 41 and a 12 month high of $89. The sector is jam-packed. View the latest Viking Therapeutics Inc. The odds of a continued upward trend are . 95, which is $2. VIKING THERAPEUTICS STOCK PRICE FORECAST TOMORROW, WEEK, 2025, 2026, 2027. 53 Viking Therapeutics, Inc. Dow Jones Forecasts – Stocks Rebound As Traders Focus On Viking Therapeutics Inc Stock forecast & analyst price target predictions, earnings, revenue ,EPS predictions, upgrades and downgrades. 25M shares outstanding). 13,051,834 shares of the company's stock were exchanged, compared to its average volume of 4,455,083. While I feel for these investors, I also believe they need to be prepared for significant volatility on a stock that isn’t expected to be profitable through the 2028 forecast period. Get AI intraday signals. The range of stock forecasts for VKTX is 38. Get The Latest VKTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. The company has a market capitalization of $4. (VKTX) range from a low of $38 to a high of $164. Analysts average stock forecasts to be materialized ratio is 72. Get latest news and stock predictions. Find the latest analyst research, reports, and ratings for Viking Therapeutics, Inc. 56 by See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. VKTX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. That means +126% from today. Common Stock (VKTX) at Nasdaq. The Viking Therapeutics Inc (VKTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $164. Upside of 242. Looking at past instances where VKTX's MACD turned positive, the stock continued to rise in of 48 cases over the following month. 25B (112. 27, which is up 108%. 0 Are The Catalysts. Viking Therapeutics Inc (VKTX) 12 Month Price Targets. Viking Therapeutics Stock Down 18. 8 Wall Street analysts that have issued a 1 year VKTX price target, the average VKTX price target is $92. com or investment advice. 95. 33 (+253. Lilly, Viking, Amgen Jump. A high-level overview of Viking Therapeutics, Inc. Nasdaq, Nyse, Euronext, and the Find the latest Viking Therapeutics, Inc. According to present data Viking Therapeutics's VKTX shares and potentially its market environment have been in VKTX : Viking Therapeutics stock forecast by Wall Street Analysts. Get stock forecasts from Wall Street's highest rated professionals. The company's announcement in February of positive results from its phase 2 study of experimental weight According to analysts, VKTX price target is 99. Also, this average forecast of $96. 33, and this show a -2. Below is a chart showing the percentage difference between Viking Therapeutics Stock Forecast 2027-2031. 17% decrease from the past average forecast of $108. 44, 6 months ago from The stock rating distribution of VKTX is 100% BUY. Viking Therapeutics stock closed the previous day at $28. Stay up-to-date with VKTX stock: Get live Viking Therapeutics, Inc prices, real-time quotes, interactive charts, and key statistics. 00 USD. 88. Following the completion of the transaction, the chief financial officer now directly owns 165,259 shares of the company's stock, valued at approximately $7,064,822. 91 per share in Broker Rating Breakdown Chart for VKTX. Wall Street Analysts Forecast Growth. Get Stock Forecast Data at your fingertips. Viking Therapeutics (NASDAQ:VKTX) quickly soared 12% amid some renewed takeover speculation for the obesity drug maker. 34 % decrease in their ownership of the stock. 95, representing a +469. Updated: 2025/03/23. Stock Analyst Price Targets - Review. Find everything from its Valuation, Future Growth, Past Performance and more. The stock has a market cap of $5. 60% of analysts recommend a Strong Buy, 35% recommend Buy, 5% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell. In this article, we are going to take a look at where Viking Therapeutics, Inc. stock forecast: Like other stocks, VKTX shares are traded on stock exchanges, e. The Viking Therapeutics, Inc. 29% from the latest price. Viking Therapeutics (VKTX) Stock Price, Quote, News & Analysis Brokerage Recommendation Trends for VKTX. 10. 60 within the first six months of the year and finish 2027 at $65. Because Viking Therapeutics is every day discovering solutions related to metabolic and endocrine disorders disease. Stay updated on market trends for VKTX. 32%) Capitalization. 42%) now ranks among the hottest biotech stocks on the market. (VKTX) Stock Forecast & Price Target. Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring Feb 05. 29 A list of analyst ratings for Viking Therapeutics (VKTX) stock. 00 with a stock forecast range of $38. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. In the past year, the stock has risen over 40% against the industry’s 11% decline. 0 %. VKTX is forecast to increase its losses from $0. VKTX traded down $8. VKTX’s Stock Price Performance & Valuation. The The forecasts for Viking Therapeutics, Inc. The 43 analysts offering price forecasts for Viking Therapeutics have a Viking Therapeutics Inc (VKTX) Stock Forecast Show ratings and price targets of : All Analysts Top Analysts Alert. This price target corresponds to an upside of 235. VKTX stock opened at $29. VKTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks. stock price prediction is currently bullish. Subscribe to unlock this section . History; Forecast; Data; Market; Q&A; Comments; Buy CRYPTO We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. 23. 55 per share by April 22, 2025. Viking Therapeutics Stock Performance. 24% price volatility over the last 30 days. Try It for Just $1. Check if this forecast comes true in a year, meanwhile watch Viking Therapeutics, Inc. Brokerage Recommendation Trends for VKTX. g. 28 on Tuesday. Get analyst recommendation and trendline forecasts for Viking Therapeutics, Inc. Cancel. 00 and a low forecast of $38. 's stock jumped 3% Tuesday, after a bullish note from Oppenheimer highlighted the company's promising obesity-drug program and its potential appeal to a deep-pocketed partner. These five years would bring a significant increase: Viking Therapeutics price would move from $54. 98%. 95 dollars the previous day. will Categories 2025 Tags vktx, vktx-2025, vktx-future-performance, vktx-growth-prospects, vktx-risks, vktx-stock, vktx-stock-forecast, vktx-stock-predictions. 48. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. According to . 67, with a high forecast of $138. com. The latest Viking Therapeutics stock prices, stock quotes, news, and VKTX history to help you invest and trade smarter. VKTX’s Detailed statistics for Viking Therapeutics, Inc. Leading pharmaceutical research agencies forecast compound annual growth rates (CAGRs) of 20-30% through 2028 (e. The forecast for beginning 28. AS OF. The 13 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 96. Check price target & stock forecast for Viking Therapeutics here>>> While the ABR calls for buying Viking Therapeutics, it may not be wise to make an Is VKTX Stock Overvalued Right Now? As the company is still pre-revenue, it's quite difficult to value the stock fundamentally. (VKTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Highest price target for VKTX is $138, Lowest price target is $71, average price target is $65. Track VIKING THERAPEUTICS, INC. 46%) Based on the Viking Therapeutics Inc stock forecast View Viking Therapeutics, Inc. Read more here. The average Viking Therapeutics stock forecast from last 6 month is $96. Average Analyst Target USD 98. 49 from the last closing price of $28. By analyzing these factors, analysts can make informed predictions about a stock’s future value. (VKTX) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Nasdaq Stock Market • NLS real time price • CURRENCY IN See Viking Therapeutics, Inc. Get much more with StockAnalysis Pro. 05, then soar to $62. The Moving Average Convergence Divergence (MACD) for VKTX turned positive on March 04, 2025. Novo Crashes 19% After New Obesity Drug Misses Forecasts. Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against the other Viking Therapeutics' stock ("Buy") is an appealing Quadrant 1 investment (high risk/high reward) and fits well in a barbell portfolio where an investor allocates 90% of their funds View the latest Viking Therapeutics Inc. 75, with the highest VKTX stock price forecast at $138. Interactive Chart for Viking Therapeutics, Inc. Based on our analysis about Viking Therapeutics Inc financial reports and earnings history, Viking Therapeutics Inc (VKTX) stock could reach $162. The stock was sold at an average price of $42. 42 during trading on Wednesday, reaching $38. 47% short interest. BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Short term VKTX stock forecast updated TODAY! Viking Therapeutics share price prediction for 2025, 2026, 2027 in the table. Feb 26, 02:12 PM (EDT) Price. 26 Get the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Viking Therapeutics stock closed at 28. 94 with a total market cap valuation of $ 3. Learn more about VKTX stock and its potential market leadership opportunities. 29 USD with a max estimate of 164. Viking Therapeutics Share Price Live: Check NASDAQ: VKTX - Viking Therapeutics stock price in INR & USD, plus analyst ratings, financials, and forecasts to aid informed decisions on Viking Therapeutics Stock with INDmoney. JPMorgan Chase & Co. 5 Breathtaking Features of the 2025 S-Class Interior. vpuij kjaw msrkl ecnf pgfvclax ndlbzw omby skvqyv fjckvwt teiyoz ukvk qme rjzxz lpktq zpb